Mosaic Immunoengineerin Financials
| CPMV Stock | USD 0.67 0.17 20.24% |
With this module, you can analyze Mosaic financials for your investing period. You should be able to track the changes in Mosaic Immunoengineerin individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Mosaic |
Understanding current and past Mosaic Immunoengineerin Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Mosaic Immunoengineerin's financial statements are interrelated, with each one affecting the others. For example, an increase in Mosaic Immunoengineerin's assets may result in an increase in income on the income statement.
The data published in Mosaic Immunoengineerin's official financial statements typically reflect Mosaic Immunoengineerin's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Mosaic Immunoengineerin's quantitative information. For example, before you start analyzing numbers published by Mosaic accountants, it's essential to understand Mosaic Immunoengineerin's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the imprecision that can be found in Mosaic Immunoengineerin's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mosaic Immunoengineering. Check Mosaic Immunoengineerin's Beneish M Score to see the likelihood of Mosaic Immunoengineerin's management manipulating its earnings.
Mosaic Immunoengineerin Stock Summary
Mosaic Immunoengineerin competes with Cell Source. Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. The company was founded in 2020 and is based in Novato, California. Mosaic Immunoengineerin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US61945M1018 |
| Business Address | 1537 South Novato |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.mosaicie.com |
| Phone | 657 208 0890 |
| Currency | USD - US Dollar |
Mosaic Immunoengineerin Key Financial Ratios
There are many critical financial ratios that Mosaic Immunoengineerin's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Mosaic Immunoengineering reports annually and quarterly.| Return On Asset | -4.2 | |||
| Beta | -1.79 | |||
| Z Score | -38.1 |
Mosaic Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mosaic Immunoengineerin's current stock value. Our valuation model uses many indicators to compare Mosaic Immunoengineerin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mosaic Immunoengineerin competition to find correlations between indicators driving Mosaic Immunoengineerin's intrinsic value. More Info.Mosaic Immunoengineering is number one stock in return on asset category among its peers. It also is the top company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mosaic Immunoengineerin's earnings, one of the primary drivers of an investment's value.Mosaic Immunoengineering Systematic Risk
Mosaic Immunoengineerin's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mosaic Immunoengineerin volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Mosaic Immunoengineering correlated with the market. If Beta is less than 0 Mosaic Immunoengineerin generally moves in the opposite direction as compared to the market. If Mosaic Immunoengineerin Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mosaic Immunoengineering is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mosaic Immunoengineerin is generally in the same direction as the market. If Beta > 1 Mosaic Immunoengineerin moves generally in the same direction as, but more than the movement of the benchmark.
Mosaic Immunoengineerin April 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Mosaic Immunoengineerin help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mosaic Immunoengineering. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mosaic Immunoengineering based on widely used predictive technical indicators. In general, we focus on analyzing Mosaic OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mosaic Immunoengineerin's daily price indicators and compare them against related drivers.
| Downside Deviation | 20.51 | |||
| Information Ratio | 0.0673 | |||
| Maximum Drawdown | 91.67 | |||
| Value At Risk | (28.57) | |||
| Potential Upside | 21.21 |
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.